The Chimeric Antigen Receptor T-Cell Construct: The Genomic Reprogramming of Hematological Oncotherapy
CAR-T cell therapy physically extracts a patient’s immune cells, genetically rewires them with synthetic targeting receptors using retroviral vectors, and injects them back into the bloodstream to hunt and destroy specific blood cancers.
